Mounjaro Price in New Zealand: What It Costs
Mounjaro pricing confirmed: $429.99 to $874.99 per month depending on dose. Full cost breakdown.

Mounjaro pricing confirmed: $429.99 to $874.99 per month depending on dose. Full cost breakdown.

Mounjaro (tirzepatide) is now available for purchase in New Zealand, with pharmacy pricing confirmed. Here's what you can expect to pay for this highly anticipated weight loss and diabetes medication.
Each Mounjaro KwikPen contains four weekly doses (one month's supply). Pricing varies by strength:
Starting and escalation doses:
Maintenance doses:
These prices are from Chemist Warehouse, which typically offers competitive pharmacy pricing and includes free shipping.
Everyone starts Mounjaro at 2.5 mg for the first four weeks. This is not a treatment dose but allows your body to adjust. After four weeks, you move to 5 mg, which is the first maintenance dose.
Your doctor may increase your dose in 2.5 mg increments every four weeks based on your response and tolerability. Many people find their optimal dose at 10 mg or 15 mg for weight management.
Typical cost progression:
If you progress to the maximum 15 mg dose, expect to pay $874.99 per month ongoing.
Pen needles: The Mounjaro KwikPen does not include needles. You'll need to purchase compatible pen needles separately, typically around $20-30 for a box that lasts several months.
Doctor consultations: You'll need a prescription from a registered healthcare professional. Online telehealth consultations or GP visits will add to your overall costs, though these are often less frequent once you're established on treatment.
No. Mounjaro is not funded by PHARMAC for weight management or type 2 diabetes. You'll pay the full private prescription cost at any pharmacy.
Wegovy (semaglutide) currently costs approximately $400-500 per month depending on pharmacy. Wegovy is the same price for all doses. Mounjaro's starting doses are competitively priced, though maintenance doses at higher strengths are more expensive.
However, clinical trials show Mounjaro delivers greater average weight loss than semaglutide. In the SURMOUNT-1 trial, participants lost up to 22.5% of body weight on the highest Mounjaro dose, compared to approximately 15% with Wegovy in comparable studies.
Mounjaro requires a prescription. You'll need a consultation with a doctor who can assess whether you're a suitable candidate based on your BMI, health history, and weight management goals.
Mounjaro is approved for adults with obesity (BMI 30 or above) or those with overweight (BMI 27 or above) who have at least one weight-related health condition such as high blood pressure, high cholesterol, sleep apnoea, or type 2 diabetes.
At Well Revolution, we offer a free initial consultation to determine if Mounjaro is safe and appropriate for you.
Concerned, need advice, a prescription, refill or referral?
Chat with a GP now